Saquinavir/ritonavir

DRUG4 trials

Sponsors

Abbott, Germans Trias i Pujol Hospital, International Antiviral Therapy Evaluation Center

Conditions

HIV Infections

Phase 1

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

CompletedNCT00307502

Germans Trias i Pujol HospitalHIV Infections

Start: 2005-01-31End: 2009-12-31Updated: 2019-12-04

Phase 2

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

CompletedNCT00038532

AbbottHIV Infections

Start: 2001-04-30Target: 24Updated: 2008-04-01

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

CompletedNCT00038519

AbbottHIV Infections

Start: 2001-04-30Target: 16Updated: 2006-07-28

Phase 4

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

CompletedNCT00389402

International Antiviral Therapy Evaluation CenterHIV Infections

Start: 2006-07-31End: 2008-07-31Target: 120Updated: 2010-06-11